✦ LIBER ✦

A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse

✍ Scribed by Park, S; Chapuis, N; Saint Marcoux, F; Recher, C; Prebet, T; Chevallier, P; Cahn, J-Y; Leguay, T; Bories, P; Witz, F; Lamy, T; Mayeux, P; Lacombe, C; Demur, C; Tamburini, J; Merlat, A; Delepine, R; Vey, N; Dreyfus, F; Béné, M C; Ifrah, N; Bouscary, D

Book ID: 121288213
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 455 KB
Volume: 27
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2013.17

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

359 Phase Ib and pharmacokinetic studies

359 Phase Ib and pharmacokinetic studies of Everolimus (RAD001), a novel oral mTOR-inhibitor, with paclitaxel in patients with advanced solid tumors

✍ M. Campone; V. Levy; V. Delecroix; E. Bourbouloux; D. Bootle; C. Tanaka; N. Shan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 144 KB

The oral mTOR inhibitor RAD001 (everolim

The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: Results of a phase I study with pharmacokinetics

✍ Ahmad Awada; Fatima Cardoso; Christel Fontaine; Luc Dirix; Jacques De Grève; Chr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 175 KB

A phase 2 study with a daily regimen of

A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer

✍ Robert J. Amato; Jaroslaw Jac; Sarah Giessinger; Somyata Saxena; James P. Willis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views

Phase I study of the oral mammalian targ

Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma

✍ Kensei Tobinai; Michinori Ogura; Dai Maruyama; Toshiki Uchida; Naokuni Uike; Ils 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 345 KB

621 POSTER A phase I study of combinatio

621 POSTER A phase I study of combination therapy with AEE788, a novel multitargeted inhibitor of ErbB and VEGF receptor family tyrosine kinases, and RAD001, a mTOR inhibitor in recurrent GBM patients

✍ D. Reardon; T. Cloughesy; J. Rich; W. Yung; C. Cilea; W. Mietlowski; L. Yung; W. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Temsirolimus, an mTOR inhibitor, in comb

Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)

✍ Sergio Amadori; Roberto Stasi; Alberto M. Martelli; Adriano Venditti; Giovanna M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB